Avalo Therapeutics
AVTX
AVTX
55 hedge funds and large institutions have $127M invested in Avalo Therapeutics in 2020 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 12 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
Holders
55
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$14.8M | |
| 2 | +$4.56M | |
| 3 | +$3.04M | |
| 4 |
SCM
Sio Capital Management
New York
|
+$2.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.63M |
Top Sellers
| 1 | -$419K | |
| 2 | -$64K | |
| 3 | -$51.3K | |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$48K |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$42K |